@MDAndersonNews/Our blood disease experts / Twitter
MD Anderson experts specializing in leukemia, lymphoma, myeloma and other blood diseases
Related Articles
Dr Tannir on Unmet Needs in the Treatment of Rare Kidney Tumors
Nizar M. Tannir, MD, FACP, discusses unmet needs for patients with rare kidney tumors and how these needs may be addressed in the future.
Vaping and your brain: What to know
Addiction researcher Francesco Versace, Ph.D., studies how the brain responds to nicotine. Here, he answers some common questions about vaping and how it impacts brain…
MD Anderson – Shop
MD Anderson – Branded Merchandise. Net proceeds support patient programs for children with cancer.
Richter transformation: What chronic lymphocytic leukemia (CLL) patients should know
Patients who have undergone treatment for chronic lymphocytic leukemia (CLL) may experience Richter transformation, a rare syndrome in which CLL turns into a more aggressive…
Study opens new avenue for immunotherapy drug development
In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method…
Sponsored: MD Anderson Cancer Center’s ‘Sprint For Life’ 5K Race/Walk
Sprint For Life raises awareness of ovarian cancer in the community and raises important research funds.
How long does it take chemotherapy to shrink tumors?
How long does it take for chemotherapy to start shrinking a tumor? Head and neck specialist and thoracic medical oncologist Janet Tu, M.D., weighs in.
Colorectal cancer survivor and employee: I now understand what makes MD Anderson No. 1
As a 12-year employee of MD Anderson, Erica Pettye never expected to face cancer herself. But the care she received here showed her why MD…
Four MD Anderson researchers elected AAAS Fellows
HOUSTON ― Recognizing their significant impacts in the realm of cancer care and research, four researchers at The University of Texas MD Anderson Cancer Center…